Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Pain Palliat Care Pharmacother ; 37(1): 106-109, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-36512682

RESUMO

Gabapentin and pregabalin both exert high affinity to the α2δ subunit of the voltage-gated calcium channels which inhibits excitatory neurotransmitter release. The synergistic mechanism was described in rats given combinations of gabapentin and pregabalin. In this case series, we described 2 cases which may illustrate the synergistic effect of gabapentin and pregabalin in treatment resistant neuropathic pain. Low dose pregabalin was added to therapeutic gabapentin to achieve appreciable pain reduction in one case and improved quality of life in another case. Further research with more enrollment and longer study duration may help elucidate the appropriate dosing and potential associated side effects.


Assuntos
Ácidos Cicloexanocarboxílicos , Neuralgia , Humanos , Ratos , Animais , Gabapentina/farmacologia , Gabapentina/uso terapêutico , Pregabalina/farmacologia , Pregabalina/uso terapêutico , Qualidade de Vida , Canais de Cálcio/uso terapêutico , Neuralgia/tratamento farmacológico , Aminas/farmacologia , Aminas/uso terapêutico , Ácidos Cicloexanocarboxílicos/farmacologia , Ácidos Cicloexanocarboxílicos/uso terapêutico , Analgésicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA